title: A rapid method to clinically assess the effect of an anti-acne formulation.
abstract: Historically, clinical evaluation of acne treatment has been based on direct visual assessment and the counting of lesions over a period of several weeks of treatment. However, with advancing technology there has been ever-increasing speed in the effectiveness of these treatments. To successfully assess these faster treatments, acne pathology needs to be evaluated in a shorter time frame. The object of these studies was to develop techniques to evaluate individual acne lesions in a shorter time frame and to assess speedier treatment technologies. Ten healthy volunteers with acne lesions on their upper backs were recruited for the study. Two inflamed acne lesions were selected for each treatment, along with lesions to be left untreated, on each volunteer. Each lesion was marked, photographed, and visually graded. A skin surface microscope (Scopeman) was used to visualize size and to grade the lesions by two experts every day for five days. The sites were treated once a day for the course of the study. There was a remarkable reduction in the size and erythema of acne lesions after treatment with the acne formulation as compared to the untreated and vehicle-treated lesions. Individual lesions, both treated and untreated, appeared resolved in 14 days. This resolution can be noticeably accelerated by topical treatments. We have developed a simple and faster clinical method to evaluate the effects of topical anti-acne technology.
authors.affiliation: Estee Lauder Companies, Melville, NY 11747, USA.
authors.forename: Neelam
authors.initials: N
authors.lastname: Muizzuddin
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Maes
authors.forename: Thomas
authors.initials: T
authors.lastname: Mammone
mesh_terms: D000152:Acne Vulgaris / Q000503:physiopathology / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004890:Erythema / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents